Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glory Days: Celebrating Two Decades of Advances in Cancer Care on the 20th Anniversary of <i>JCO Oncology Practice</i>.

JCO oncology practice·2025
Same author

Predicting Depression Risk in Patients With Cancer Using Multimodal Data: Algorithm Development Study.

JMIR medical informatics·2024
Same author

Computing the Cost of Care per Patient per Day for Patients With Metastatic Neuroendocrine Neoplasms.

JCO oncology practice·2023
Same author

Grade 4 Neutropenia Frequency as a Binary Risk Predictor for Adverse Clinical Consequences of Chemotherapy‑Induced Neutropenia: A Meta-analysis.

Cancer investigation·2023
Same author

Machine Learning Applied to Electronic Health Records: Identification of Chemotherapy Patients at High Risk for Preventable Emergency Department Visits and Hospital Admissions.

JCO clinical cancer informatics·2021
Same author

Reply to Ritzwoller et al.

JCO clinical cancer informatics·2021
Same journal

Advancing the Oncology Data Paradigm: Multisite Expansion of Structured Cancer Data Capture at the Point of Care.

JCO oncology practice·2026
Same journal

Clinical Research in Community Oncology: Advancing Cancer Care Through Localized Clinical Trials.

JCO oncology practice·2026
Same journal

Glucagon-Like Peptide-1 Receptor Agonists in Breast Cancer: Metabolic, Clinical, and Survivorship Implications.

JCO oncology practice·2026
Same journal

Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program.

JCO oncology practice·2026
Same journal

Implementing Systems-Based Interventions to Improve the Care of Cancer Survivors: Small Steps, Large Challenges.

JCO oncology practice·2026
Same journal

Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer Surgery.

JCO oncology practice·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Don't Cancer Doctors Offer Good-Quality Care?

Douglas W Blayney1, Micheal N Neuss2

  • 1Stanford Medicine, Stanford University School of Medicine, Stanford, CA.

JCO Oncology Practice
|June 8, 2026
PubMed
Summary
This summary is machine-generated.

Quality improvement in oncology care faces challenges in demonstrating value. Future success requires physician-led initiatives, leveraging AI and data sharing for integrated quality measurement.

Related Experiment Videos

Last Updated: Jun 10, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Area of Science:

  • Oncology
  • Healthcare Quality Improvement
  • Health Policy

Background:

  • The evolution of oncology quality improvement spans over a century, from early standards to sophisticated registries and frameworks like Donabedian's structure-process-outcome.
  • Initiatives such as the American Society of Clinical Oncology's (ASCO) Quality Oncology Practice Initiative (QOPI) aimed to drive improvement through physician-led self-assessment.

Purpose of the Study:

  • To provide perspectives on the successes and challenges of quality improvement (QI) in oncology care over the past 25 years.
  • To evaluate the effectiveness of payment reforms and private payer initiatives in improving oncology care quality and reducing costs.
  • To identify contemporary challenges and propose future directions for quality improvement in cancer care.

Main Methods:

  • Retrospective review of historical quality improvement efforts and policy changes in oncology.
  • Analysis of the impact of Medicare payment reforms (RBRVS, OCM, Enhancing Oncology Model) and private payer initiatives.
  • Discussion of current challenges including healthcare system integration, rising costs, and physician burnout.

Main Results:

  • Despite numerous efforts, demonstrating the value of high-quality oncology care to stakeholders remains a significant challenge.
  • Medicare payment reforms and private payer initiatives have yielded mixed results, with limited improvements in quality measures and cost savings.
  • Current challenges persist, including vertical integration, high drug costs, physician burnout, and declining public trust.

Conclusions:

  • Future advancements in oncology quality improvement necessitate a return to physician-led, bottom-up approaches.
  • Leveraging artificial intelligence (AI) for clinical documentation and data-sharing technologies is crucial for seamless quality measurement.
  • Integrating quality measurement as an inherent part of cancer care, rather than an external imposition, is key to achieving better outcomes.